×
Tuesday, May 18, 2021

Coronavirus Effects on Medical Billing: Preparing to Use the New ICD-10 COVID-19 Codes

Last updated Friday, May 22, 2020 11:39 ET

Coronavirus Effects on Medical Billing: Preparing to Use the New ICD-10 COVID-19 Codes

Staten Island, United States, 05/22/2020 / SubmitMyPR /

As the novel coronavirus continues to take hold throughout the country and healthcare facilities attempt to quickly reconfigure care delivery for patients and consumers who are being advised to stay home and not seek non-emergent care at hospitals and other facilities, appointments are being cancelled nationwide.  Some care organizations and practices already have telehealth systems in place, while others are scrambling to develop or increase that capacity.

In turn, providers are facing new challenges in preparing to bill for telehealth services when patients can’t make in-facility appointments due to precaution, self-quarantine, containment, and even potential regional quarantines. The Centers for Disease Control and Prevention (CDC), effective immediately, has released new ICD-10 diagnosis codes for billing associated with COVID-19. 

Following is an update on and guidance for preparing to use the new codes when delivering services directly or via telehealth technology to patients whose care or care-seeking activities are affected by the coronavirus:

  • Remember that when billing for telehealth patient phone calls, providers can use the same office visit and diagnosis codes they would regularly use for an office visit but need an additional modifier to bill. They also must use the place of service as 02 to designate that the place of service was telehealth.
  • Always check with local insurance carriers to verify coverage of telehealth, even though most insurance companies now offer coverage.  Some states are mandating the coverage so that patients won’t have to go without treatment, and the availability of telehealth billing can help practices mitigate cash-flow interruptions in these uncertain times.
  • Exposure to COVID-19.  For cases where there is a concern about a possible exposure to COVID-19, but this is ruled out after evaluation, it is appropriate to assign the code Z03.818, “Encounter for observation for suspected exposure,” with other biological agents ruled out.
  • For cases where there is an actual exposure to someone who is confirmed to have COVID-19, it is appropriate to assign the code Z20.828, “Contact with and (suspected) exposure to other viral communicable diseases.”
  • Signs and symptoms.  For patients presenting with any signs/symptoms (such as fever, cough or respiratory symptoms) and where a definitive diagnosis has not been established, assign the appropriate code(s) for each of the presenting signs and symptoms such as:  R05 Cough, R06.02 Shortness of breath, R50.9 Fever or unspecified.
  • Note:  Diagnosis code B34.2, “Coronavirus infection, unspecified,” would generally not be appropriate for the COVID-19, because the cases have universally been respiratory in nature, so the site would not be “unspecified.”
  • If the provider documents “suspected,” “possible” or “probable” COVID-19, do not assign code B97.29. Assign a code(s) explaining the reason for encounter (such as fever, or Z20.828).

This coding guidance has been developed by the CDC and approved by the four organizations that make up the Cooperating Parties:  the National Center for Health Statistics, the American Health Information Management Association, the American Hospital Association, and the Centers for Medicare & Medicaid Services.

For more information on providing healthcare services during and in light of growing coronavirus cases, refer to the CDC’s COVID-19 clinical presentation and stay up to date on developments by regularly visiting the CDC’s website.

https://www.bymedicalbilling.com


Content Disclaimer: 

The above review statements are those of the sponsor (Source of content) and do not necessarily reflect the official policy, position or views of the content publisher. The content distribution company is therefore not responsible for the content and its authenticity and legal standing of the above subject matter. Each individual is required to exercise its content when making a purchase from the above offer. The information does not constitute advice or an offer to buy. Any purchase made from the above press release is made at your own risk. Editorial merit of this content is subject to news publisher and its downstream partners. Consult an expert advisor/health and professional advisor before any such purchase. Any purchase made from this link is subject to the final terms and conditions of the website's selling as mentioned in the above as source. The content publisher and its downstream distribution partners do not take any responsibility directly or indirectly. If you have any complaints or copyright issues related to this article, kindly contact the company this news is about.  

DISCLAIMER of Liability. IN NO EVENT SHALL OUR PR COMPANY BE LIABLE OR RESPONSIBLE TO YOU OR ANY OTHER PERSON FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES OF ANY KIND, INCLUDING WITHOUT LIMITATION, LOST PROFITS OR LOST OPPORTUNITIES, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES IN ADVANCE AND REGARDLESS OF THE CAUSE OF ACTION UPON WHICH ANY SUCH CLAIM IS BASED, INCLUDING, WITHOUT LIMITATION, ANY CLAIM ARISING OUT OF OR IN CONNECTION WITH ANY OF THE CONTENT, INCLUDING, WITHOUT LIMITATION, AUDIO, PHOTOGRAPHS, AND VIDEOS, OR OF THE ACCURACY, RELIABILITY, OR LEGALITY OF ANY STATEMENT MADE IN OR OMITTED FROM ANY advertisement, sponsorship, endorsement, testimonial, opinion, or other product-related or service-related statement or review appearing in the Websites or in ANY post or article distributed via the Websites.